首页> 外文会议>International Conference on Chemical, Biological and Environmental Engineering >MOLECULAR DOCKING OF 3-O-MICAROCYLMICAMINOCYL-5-O-FOROSAMINYLERYTHRONOLIDE-B (MMFE) TO RRNA 23S DEINOCOCCUSRADIODURANS AND THE PREDICTION OF ITS ANTIBIOTIC POTENCY
【24h】

MOLECULAR DOCKING OF 3-O-MICAROCYLMICAMINOCYL-5-O-FOROSAMINYLERYTHRONOLIDE-B (MMFE) TO RRNA 23S DEINOCOCCUSRADIODURANS AND THE PREDICTION OF ITS ANTIBIOTIC POTENCY

机译:将3-O-micrarodylmicaminodyl-5-O-氨基氨基氨基酚醇的分子对接至rRNA 23s Deinococcus radiodurans的预测和预测其抗生素效力

获取原文

摘要

MMFE is a new derivative of erythromycin which is synthesized through hybrid biosynthetic technique. The molecular docking to rRNA 23S Deinicoccus radiodurans is accomplished to determine the model and strength of binding to the target macromolecule. The molecular docking of erythromycin-A to the same macromolecule is used as a control. The docking result of MMFE shows that it occupies the same cavity as of the experimental erythromycin-A in the same macromolecule. The binding position of MMFE is not exactly the same as erythromycin-A due to the presence of glycon dimer of MMFE molecules. According to free energy of binding, MMFE is predictably a higher potency than erythromycin-A.
机译:MMFE是通过混合生物合成技术合成的红霉素的新衍生物。完成对RRNA 23S的分子对接,以确定与靶大分子结合的模型和强度。使用红霉素-A至同一大分子的分子对接用作对照。 MMFE的对接结果表明它占据了同一大分子中的实验性红霉素-A的相同空腔。由于MMFE分子的Glycon二聚体存在,MMFE的结合位置与红霉素-A完全相同。根据结合的自由能量,MMFE可预测较高的效力,而不是红霉素-A。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号